세계의 세포 동결보존액 시장 : 시장 점유율과 순위, 전체 매출 및 수요 예측(2025-2031년)

The global market for Cell Cryopreservation Solution was estimated to be worth US$ 118.34 million in 2024. It is forecast to a readjusted size of US$ 158.92 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.

The global key companies of Cell Cryopreservation Solution include Fujifilm, Thermo Fisher Scientific, BioLife Solutions, Sartorius, Cytiva, WAK-Chemie Medical, Zenoaq, Merck, and Vitrolife Group, etc. In 2024, the global five largest players hold a share approximately 57.4% in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Cell Cryopreservation Solution, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Cell Cryopreservation Solution by region & country, by Type, and by Application.

The Cell Cryopreservation Solution market size, estimations, and forecasts are provided in terms of sales volume (K L) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Cryopreservation Solution.

Market Segmentation

By Company

• Fujifilm
• Thermo Fisher Scientific
• BioLife Solutions
• Sartorius
• Cytiva
• WAK-Chemie Medical
• Zenoaq
• Merck
• Vitrolife Group
• Lifeline
• Capricorn
• BioLegend
• Miltenyi Biotec
• CooperSurgical
• Yocon Biology
• Selcell
• Shanghai Epizyme
• ExCell Bio

Segment by Type

• Serum-free Cell Freezing Medium
• Serum Cell Freezing Medium

Segment by Application

• Biotechnology Company
• Universities and Research Institutes
• Hospital

By Region

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• U.K.
• Italy
• Spain
• Rest of Europe
• Latin America
• Mexico
• Brazil
• Rest of Latin America
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE
• Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Cell Cryopreservation Solution manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Cell Cryopreservation Solution in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Cell Cryopreservation Solution in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Cell Cryopreservation Solution Product Introduction
• 1.2 Global Cell Cryopreservation Solution Market Size Forecast
  • 1.2.1 Global Cell Cryopreservation Solution Sales Value (2020-2031)
  • 1.2.2 Global Cell Cryopreservation Solution Sales Volume (2020-2031)
  • 1.2.3 Global Cell Cryopreservation Solution Sales Price (2020-2031)
• 1.3 Cell Cryopreservation Solution Market Trends & Drivers
  • 1.3.1 Cell Cryopreservation Solution Industry Trends
  • 1.3.2 Cell Cryopreservation Solution Market Drivers & Opportunity
  • 1.3.3 Cell Cryopreservation Solution Market Challenges
  • 1.3.4 Cell Cryopreservation Solution Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Cell Cryopreservation Solution Players Revenue Ranking (2024)
• 2.2 Global Cell Cryopreservation Solution Revenue by Company (2020-2025)
• 2.3 Global Cell Cryopreservation Solution Players Sales Volume Ranking (2024)
• 2.4 Global Cell Cryopreservation Solution Sales Volume by Company Players (2020-2025)
• 2.5 Global Cell Cryopreservation Solution Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Cell Cryopreservation Solution Headquarters
• 2.7 Key Manufacturers Cell Cryopreservation Solution Product Offered
• 2.8 Key Manufacturers of Cell Cryopreservation Solution, Date of Establishment
• 2.9 Cell Cryopreservation Solution Market Competitive Analysis
  • 2.9.1 Cell Cryopreservation Solution Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 Largest Manufacturers by Cell Cryopreservation Solution Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Cryopreservation Solution as of 2024)

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Serum-free Cell Freezing Medium
  • 3.1.2 Serum Cell Freezing Medium
• 3.2 Global Cell Cryopreservation Solution Sales Value by Type
  • 3.2.1 Global Cell Cryopreservation Solution Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Cell Cryopreservation Solution Sales Value, by Type (2020-2031)
  • 3.2.3 Global Cell Cryopreservation Solution Sales Value, by Type (%) (2020-2031)
• 3.3 Global Cell Cryopreservation Solution Sales Volume by Type
  • 3.3.1 Global Cell Cryopreservation Solution Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Cell Cryopreservation Solution Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Cell Cryopreservation Solution Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Cell Cryopreservation Solution Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Biotechnology Company
  • 4.1.2 Universities and Research Institutes
  • 4.1.3 Hospital
• 4.2 Global Cell Cryopreservation Solution Sales Value by Application
  • 4.2.1 Global Cell Cryopreservation Solution Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Cell Cryopreservation Solution Sales Value, by Application (2020-2031)
  • 4.2.3 Global Cell Cryopreservation Solution Sales Value, by Application (%) (2020-2031)
• 4.3 Global Cell Cryopreservation Solution Sales Volume by Application
  • 4.3.1 Global Cell Cryopreservation Solution Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Cell Cryopreservation Solution Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Cell Cryopreservation Solution Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Cell Cryopreservation Solution Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Cell Cryopreservation Solution Sales Value by Region
  • 5.1.1 Global Cell Cryopreservation Solution Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Cell Cryopreservation Solution Sales Value by Region (2020-2025)
  • 5.1.3 Global Cell Cryopreservation Solution Sales Value by Region (2026-2031)
  • 5.1.4 Global Cell Cryopreservation Solution Sales Value by Region (%), (2020-2031)
• 5.2 Global Cell Cryopreservation Solution Sales Volume by Region
  • 5.2.1 Global Cell Cryopreservation Solution Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Cell Cryopreservation Solution Sales Volume by Region (2020-2025)
  • 5.2.3 Global Cell Cryopreservation Solution Sales Volume by Region (2026-2031)
  • 5.2.4 Global Cell Cryopreservation Solution Sales Volume by Region (%), (2020-2031)
• 5.3 Global Cell Cryopreservation Solution Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Cell Cryopreservation Solution Sales Value, 2020-2031
  • 5.4.2 North America Cell Cryopreservation Solution Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Cell Cryopreservation Solution Sales Value, 2020-2031
  • 5.5.2 Europe Cell Cryopreservation Solution Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Cell Cryopreservation Solution Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Cell Cryopreservation Solution Sales Value by Region (%), 2024 VS 2031
• 5.7 Latin America
  • 5.7.1 Latin America Cell Cryopreservation Solution Sales Value, 2020-2031
  • 5.7.2 Latin America Cell Cryopreservation Solution Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Cell Cryopreservation Solution Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Cell Cryopreservation Solution Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Cell Cryopreservation Solution Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Cell Cryopreservation Solution Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Cell Cryopreservation Solution Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Cell Cryopreservation Solution Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Cell Cryopreservation Solution Sales Value, 2020-2031
  • 6.3.2 United States Cell Cryopreservation Solution Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Cell Cryopreservation Solution Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Cell Cryopreservation Solution Sales Value, 2020-2031
  • 6.4.2 Europe Cell Cryopreservation Solution Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Cell Cryopreservation Solution Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Cell Cryopreservation Solution Sales Value, 2020-2031
  • 6.5.2 China Cell Cryopreservation Solution Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Cell Cryopreservation Solution Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Cell Cryopreservation Solution Sales Value, 2020-2031
  • 6.6.2 Japan Cell Cryopreservation Solution Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Cell Cryopreservation Solution Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Cell Cryopreservation Solution Sales Value, 2020-2031
  • 6.7.2 South Korea Cell Cryopreservation Solution Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Cell Cryopreservation Solution Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Cell Cryopreservation Solution Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Cell Cryopreservation Solution Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Cell Cryopreservation Solution Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Cell Cryopreservation Solution Sales Value, 2020-2031
  • 6.9.2 India Cell Cryopreservation Solution Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Cell Cryopreservation Solution Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Fujifilm
  • 7.1.1 Fujifilm Company Information
  • 7.1.2 Fujifilm Introduction and Business Overview
  • 7.1.3 Fujifilm Cell Cryopreservation Solution Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 Fujifilm Cell Cryopreservation Solution Product Offerings
  • 7.1.5 Fujifilm Recent Development
• 7.2 Thermo Fisher Scientific
  • 7.2.1 Thermo Fisher Scientific Company Information
  • 7.2.2 Thermo Fisher Scientific Introduction and Business Overview
  • 7.2.3 Thermo Fisher Scientific Cell Cryopreservation Solution Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 Thermo Fisher Scientific Cell Cryopreservation Solution Product Offerings
  • 7.2.5 Thermo Fisher Scientific Recent Development
• 7.3 BioLife Solutions
  • 7.3.1 BioLife Solutions Company Information
  • 7.3.2 BioLife Solutions Introduction and Business Overview
  • 7.3.3 BioLife Solutions Cell Cryopreservation Solution Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 BioLife Solutions Cell Cryopreservation Solution Product Offerings
  • 7.3.5 BioLife Solutions Recent Development
• 7.4 Sartorius
  • 7.4.1 Sartorius Company Information
  • 7.4.2 Sartorius Introduction and Business Overview
  • 7.4.3 Sartorius Cell Cryopreservation Solution Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 Sartorius Cell Cryopreservation Solution Product Offerings
  • 7.4.5 Sartorius Recent Development
• 7.5 Cytiva
  • 7.5.1 Cytiva Company Information
  • 7.5.2 Cytiva Introduction and Business Overview
  • 7.5.3 Cytiva Cell Cryopreservation Solution Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 Cytiva Cell Cryopreservation Solution Product Offerings
  • 7.5.5 Cytiva Recent Development
• 7.6 WAK-Chemie Medical
  • 7.6.1 WAK-Chemie Medical Company Information
  • 7.6.2 WAK-Chemie Medical Introduction and Business Overview
  • 7.6.3 WAK-Chemie Medical Cell Cryopreservation Solution Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 WAK-Chemie Medical Cell Cryopreservation Solution Product Offerings
• 7.7 Zenoaq
  • 7.7.1 Zenoaq Company Information
  • 7.7.2 Zenoaq Introduction and Business Overview
  • 7.7.3 Zenoaq Cell Cryopreservation Solution Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 Zenoaq Cell Cryopreservation Solution Product Offerings
• 7.8 Merck
  • 7.8.1 Merck Company Information
  • 7.8.2 Merck Introduction and Business Overview
  • 7.8.3 Merck Cell Cryopreservation Solution Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 Merck Cell Cryopreservation Solution Product Offerings
  • 7.8.5 Merck Recent Development
• 7.9 Vitrolife Group
  • 7.9.1 Vitrolife Group Company Information
  • 7.9.2 Vitrolife Group Introduction and Business Overview
  • 7.9.3 Vitrolife Group Cell Cryopreservation Solution Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.9.4 Vitrolife Group Cell Cryopreservation Solution Product Offerings
  • 7.9.5 Vitrolife Group Recent Development
• 7.10 Lifeline
  • 7.10.1 Lifeline Company Information
  • 7.10.2 Lifeline Introduction and Business Overview
  • 7.10.3 Lifeline Cell Cryopreservation Solution Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.10.4 Lifeline Cell Cryopreservation Solution Product Offerings
• 7.11 Capricorn
  • 7.11.1 Capricorn Company Information
  • 7.11.2 Capricorn Introduction and Business Overview
  • 7.11.3 Capricorn Cell Cryopreservation Solution Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.11.4 Capricorn Cell Cryopreservation Solution Product Offerings
• 7.12 BioLegend
  • 7.12.1 BioLegend Company Information
  • 7.12.2 BioLegend Introduction and Business Overview
  • 7.12.3 BioLegend Cell Cryopreservation Solution Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.12.4 BioLegend Cell Cryopreservation Solution Product Offerings
  • 7.12.5 BioLegend Recent Development
• 7.13 Miltenyi Biotec
  • 7.13.1 Miltenyi Biotec Company Information
  • 7.13.2 Miltenyi Biotec Introduction and Business Overview
  • 7.13.3 Miltenyi Biotec Cell Cryopreservation Solution Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.13.4 Miltenyi Biotec Cell Cryopreservation Solution Product Offerings
• 7.14 CooperSurgical
  • 7.14.1 CooperSurgical Company Information
  • 7.14.2 CooperSurgical Introduction and Business Overview
  • 7.14.3 CooperSurgical Cell Cryopreservation Solution Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.14.4 CooperSurgical Cell Cryopreservation Solution Product Offerings
  • 7.14.5 CooperSurgical Recent Development
• 7.15 Yocon Biology
  • 7.15.1 Yocon Biology Company Information
  • 7.15.2 Yocon Biology Introduction and Business Overview
  • 7.15.3 Yocon Biology Cell Cryopreservation Solution Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.15.4 Yocon Biology Cell Cryopreservation Solution Product Offerings
• 7.16 Selcell
  • 7.16.1 Selcell Company Information
  • 7.16.2 Selcell Introduction and Business Overview
  • 7.16.3 Selcell Cell Cryopreservation Solution Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.16.4 Selcell Cell Cryopreservation Solution Product Offerings
• 7.17 Shanghai Epizyme
  • 7.17.1 Shanghai Epizyme Company Information
  • 7.17.2 Shanghai Epizyme Introduction and Business Overview
  • 7.17.3 Shanghai Epizyme Cell Cryopreservation Solution Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.17.4 Shanghai Epizyme Cell Cryopreservation Solution Product Offerings
  • 7.17.5 Shanghai Epizyme Recent Development
• 7.18 ExCell Bio
  • 7.18.1 ExCell Bio Company Information
  • 7.18.2 ExCell Bio Introduction and Business Overview
  • 7.18.3 ExCell Bio Cell Cryopreservation Solution Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.18.4 ExCell Bio Cell Cryopreservation Solution Product Offerings

8 Industry Chain Analysis

• 8.1 Cell Cryopreservation Solution Industrial Chain
• 8.2 Cell Cryopreservation Solution Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Cell Cryopreservation Solution Sales Model
  • 8.5.2 Cell Cryopreservation Solution Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
  • 10.1.2 Data Source
• 10.2 Author Details
• 10.3 Disclaimer 142